An Introduction to Cellular Therapy for Lung Disease

Cells are the building blocks of life; they are essential to every living organism. They are able to self-renew and replicate—with the ability to form every type of tissue or organ in the body. Cells from one organ are able to create tissue for another organ; this is called plasticity. This is key to their function as a regenerative medicine.

How Does Cellular Therapy Work?

Cells can be transferred into any single organ in the body since cells have the capacity to develop into many possible differentiated cells. Since they are capable of self-renewing indefinitely, they will divide many times and will specialize to promote the healing of organs while still sustaining the original undifferentiated cell.

Cells Used in Regenerative Therapy

While there are many options for the type of cells used in the world, the Lung Institute only treats with autologous cells. This means the cells are directly coming from an adult patient’s own body. This decreases the possibility of rejection and eliminates any possible controversy associated with cells.

The Lung Institute offers cellular therapy: Blood-Derived Therapy. During the therapy, the cells go through a specific process in order to be ready to help people breathe better.

The Regenerative Therapy Process

The cells are extracted from the patient’s body through blood. The cells are then  isolated by a trained professional. Almost immediately, the cells are returned to the patient intravenously. Once the cells are returned to the patient, they will begin to promote the healing of lung tissue. With their ability to continually replicate, the lungs grow stronger, and patients are able to breathe easier.

If you or a loved one want to learn more about how cellular therapy can be used to combat lung disease, contact us or call us at 888-745-6697.

*For more information, go to

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.